Temporal evolution of liver cancer etiology in China, 1990–2021: insights from the Global Burden of Disease Study 2021
The prevention and management of HBV infection in China have been efficient; however, the prevalence of metabolic illnesses in the etiology of liver cancer has escalated, and aging alongside population expansion has positively contributed to the increasing burden of liver cancer.
Authors
- Ade Su
- Sheng Yang (ORCID: https://orcid.org/0000-0003-3657-8771)
- S Wang
- WenCe Zhou
- Tao Luo (ORCID: https://orcid.org/0009-0009-3166-3943)
- Xuean Zhao
- Jianqi Qin
Institutions
- Shanxi Medical University (CN)
- Second Hospital of Shanxi Medical University (CN)
Publication Details
- Journal
- Chinese Clinical Oncology
- Published
- 2025-12-01
- DOI
- https://doi.org/10.21037/cco-25-80
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00